Market closedNon-fractional

Conmed/CNMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Conmed

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Ticker

CNMD

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Equipment and Supplies

Headquarters

Largo, United States

Employees

4,000

Conmed Metrics

BasicAdvanced
$2.2B
Market cap
27.50
P/E ratio
$2.60
EPS
1.42
Beta
$0.80
Dividend rate
1.12%
Dividend yield
$2.2B
1.42
$0.80
2.182
0.945
115.848
115.929
29.82%
3.82%
3.68%
10.25%
27.499
1.744
2.56
-3.69
15.552
1.12%
14.83%
-182.79%
12.71%
80.57%

What the Analysts think about Conmed

Analyst Ratings

Majority rating from 8 analysts.
Buy

Conmed Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
6.31% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$312M
-4.53%
Net income
$20M
-40.30%
Profit margin
6.31%
-37.46%

Conmed Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.01%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.83
$0.90
$1.06
$0.79
-
Expected
$0.79
$0.83
$1.11
$0.74
$0.91
Surprise
4.49%
8.43%
-4.50%
7.01%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Conmed stock?

Conmed (CNMD) has a market cap of $2.2B as of July 25, 2024.

What is the P/E ratio for Conmed stock?

The price to earnings (P/E) ratio for Conmed (CNMD) stock is 27.5 as of July 25, 2024.

Does Conmed stock pay dividends?

Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of July 25, 2024, the dividend rate is $0.8 and the yield is 1.12%. Conmed has a payout ratio of 29.82% on a trailing twelve-month basis.

When is the next Conmed dividend payment date?

The next Conmed (CNMD) dividend payment date is unconfirmed.

What is the beta indicator for Conmed?

Conmed (CNMD) has a beta rating of 1.42. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Conmed stock

Buy or sell Conmed stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing